| Authors | Oliver W Press |
| Journal | Journal of clinical oncology : official journal of the American Society of Clinical Oncology
(J Clin Oncol)
Vol. 26
Issue 32
Pg. 5147-50
(Nov 10 2008)
ISSN: 1527-7755 [Electronic] United States |
| PMID | 18854559
(Publication Type: Editorial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Comment)
|
| Chemical References |
- Antibodies, Monoclonal
- Antigens, CD20
- ibritumomab tiuxetan
|
| Topics |
- Antibodies, Monoclonal
(adverse effects, therapeutic use)
- Antigens, CD20
(analysis)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Chemotherapy, Adjuvant
- Disease-Free Survival
- Evidence-Based Medicine
- Humans
- Lymphoma, B-Cell
(drug therapy, immunology, pathology, radiotherapy)
- Neoplasm Staging
- Radioimmunotherapy
- Radiotherapy, Adjuvant
- Research Design
- Time Factors
- Treatment Outcome
|
